secwatch / observer
8-K filed April 28, 2025, 7:59 PM ET ticker UTHR CIK 0001082554
debt confidence high sentiment neutral materiality 0.50

UNITED THERAPEUTICS Corp (UTHR): debt financing — United Therapeutics enters $2.5B revolving credit facility, repays $200M of existing debt

UNITED THERAPEUTICS Corp

item 1.01item 1.02item 2.03item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

UNITED THERAPEUTICS Corp incurred revolving credit of up to $2.5 billion with Wells Fargo Bank, National Association at an adjusted Term SOFR rate or a fluctuating base rate, in each case, plus an app maturing five years after the closing date of the Credit Agreement.

Instrument
revolving credit
Principal
up to $2.5 billion
Counterparty
Wells Fargo Bank, National Association
Rate
an adjusted Term SOFR rate or a fluctuating base rate, in each case, plus an app
Maturity
five years after the closing date of the Credit Agreement
Event
incurrence
Exact text from the filing
National Association (“ Wells Fargo ”), as administrative agent and as a swingline lender. The Credit Agreement provides for an unsecured, revolving credit facility of up to $2.5 billion (which facility may, subject to obtaining commitments from existing or new lenders for such increase and subject to other condition, be increased by up to $750 million in the
View on SEC.gov

Browse all debt financings →

UNITED THERAPEUTICS Corp filing history →

Source: SEC EDGAR
accession 0001104659-25-039710
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.